Shares of TransMedics (TMDX) are falling after Scorpion Capital revealed its short position on the company Friday. The ...

Short seller Scorpion Capital disclosed a short position in TransMedics Group Inc (NASDAQ:TMDX) accusing the organ transplant tech. company of fraudulent practices, including kickbacks, billing fraud, ...

EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...

The big sell-off came after activist short seller Scorpion Capital released a scathing report about TransMedics. Scorpion stated in its report, "TransMedics is the most extreme and grotesque ...

On January 10, 2025, Bloomberg reported TransMedics shares dropped“as much as 13% after Scorpion Capital said it is short the transplant-therapy company's stock.” ...

This should act as a reminder of the risks the industry faces. We sell different types of products and services to both investment professionals and individual investors. These products and ...

TransMedics Group (NASDAQ:TMDX) experienced a sharp decline in its stock price today, falling over 15% following the release of a critical report by Scorpion Capital. The report accuses the company of ...